Table 1.
Baseline characteristics of the study population
| Patient # | Sex | Age (in years) | History of PSC | BMI | CA19.9 (in kU/L) | Glucose levels (mmol/L)* |
|---|---|---|---|---|---|---|
| 1 | F | 81 | - | 27.9 | 183 | 6.1 |
| 2 | M | 69 | - | 25.7 | 348 | 4.5 |
| 3 | F | 61 | + | 25.1 | 111 | 6.2 |
| 4 | M | 74 | - | 24.4 | 1096 | 5.3 |
| 5 | M | 79 | + | 20.9 | 1987 | 6.2 |
| 6 | M | 69 | - | 25.3 | 99 | 7.2 |
| 7 | F | 68 | - | 22.6 | 284 | 6.9 |
| 8 | F | 64 | - | 26.9 | < 2 | 5.7 |
| 9 | M | 52 | - | 26.2 | 6802 | 5.8 |
| 10 | M | 61 | + | 22.4 | - | 6.3 |
| 11 | M | 56 | - | 23.4 | 11 | 5.1 |
| 12 | M | 50 | + | 23.2 | 14 | 6.1 |
| 13 | F | 28 | + | 28.4 | 159 | 5.3 |
| 14 | M | 61 | - | 28.6 | < 2 | 6.0 |
BMI = Body Mass Index, PSC = Primary Sclerosing Cholangitis
* = Prior to PET/MRI